Trial Profile
Prospective observational data on 30 patients starting fingolimod before the age of 21 years
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Feb 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 18 Feb 2016 New trial record